AII
HAE icon

AGF Investments Inc’s Haemonetics HAE Stock Holding History

AGF Investments Inc’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-8
Closed -$1K – 841
2020
Q2 		$1K Hold
8
– – ﹤0.01% 800
2020
Q1 		$1K Buy
+8
New +$867 ﹤0.01% 787
2014
Q2 		– Sell
-234
Closed -$8K – 405
2014
Q1 		$8K Hold
234
– – ﹤0.01% 403
2013
Q4 		$10K Buy
+234
New +$9.63K ﹤0.01% 407

Other funds holding HAE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AGF Investments Inc's HAE Position: Q3 2020 in Review

AGF Investments Inc sold out of Haemonetics (HAE) in Q3 2020, closing a stake of 8 shares — an estimated $1K sold.

AGF Investments Inc first reported a position in HAE in Q4 2013 and held it in 4 quarters. The position peaked at $10K in Q4 2013. 268 funds tracked by Wall St. Rank hold HAE as of Q3 2020.

  • AGF Investments Inc reported no remaining Haemonetics position as of Q3 2020 after selling out during the quarter.
  • AGF Investments Inc sold 8 Haemonetics shares in Q3 2020, an estimated $1K.
  • AGF Investments Inc first reported a position in Haemonetics in Q4 2013 and held it in 4 quarters.
  • AGF Investments Inc's Haemonetics position peaked at $10K in Q4 2013.
  • 268 funds tracked by Wall St. Rank held Haemonetics as of Q3 2020.

Based on AGF Investments Inc's 13F filing for Q3 2020, filed 12 Nov 2020.